Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia

Brain

Volumn 135, Issue 2, 2012, Pages 506-520

  Danesh Meyer, Helen V ^a   Kerr, Nathan M ^a   Zhang, Jie ^a   Eady, Elizabeth K ^a   O'Carroll, Simon J ^a   Nicholson, Louise F B ^a   Johnson, Cameron S ^a   Green, Colin R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

central nervous system ischaemia; connexin43; neuroprotection; retinal ganglion cells; retinal ischaemia

Indexed keywords

CONNEXIN 43; CONNEXIN 43 MIMETIC PEPTIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; PEPTIDOMIMETIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BLOOD VESSEL PERMEABILITY; BRAIN ISCHEMIA; CELL ACTIVATION; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; IMMUNOREACTIVITY; MALE; MOUSE; MUELLER CELL; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; RETINA BLOOD VESSEL; RETINA GANGLION CELL; RETINA ISCHEMIA;

EID: 84863131028     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr338     Document Type: Article

References (65)

1. Abcouwer SF, Lin C-m, Wolpert EB, Shanmugam S, Schaefer EW, Freeman WM, et al. Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2010; 51: 5920-33.
2. Adachi K, Fujita Y, Morizane C, Akaike A, Ueda M, Satoh M, et al. Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina. Eur J Pharmacol 1998; 350: 53-7. (Pubitemid 28288308)
3. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 2004; 16: 1-13. (Pubitemid 38569790)
4. Braet K, Paemeleire K, D'Herde K, Sanderson MJ, Leybaert L. Astrocyte-endothelial cell calcium signals conveyed by two signalling pathways. Eur J Neurosci 2001; 13: 79-91. (Pubitemid 32055868)
5. Braet K, Aspeslagh S, Vandamme W, Willecke K, Martin PE, Evans WH, et al. Pharmacological sensitivity of ATP release triggered by photoliberation of inositol-1,4,5-trisphosphate and zero extracellular calcium in brain endothelial cells. J Cell Physiol 2003; 197: 205-13. (Pubitemid 37485249)
6. Brandstatter JH, Hartveit E, Sassoe-Pognetto M, Wassle H. Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci 1994; 6: 1100-12. (Pubitemid 24218385)
7. Cheon EW, Park CH, Kang SS, Cho GJ, Yoo JM, Song JK, et al. Nitric oxide synthase expression in the transient ischemic rat retina: neuroprotection of betaxolol. Neurosci Lett 2002; 330: 265-9. (Pubitemid 35254050)
8. Cheon EW, Park CH, Kang SS, Cho GJ, Yoo JM, Song JK, et al. Change in endothelial nitric oxide synthase in the rat retina following transient ischemia. Neuroreport 2003; 14: 329-33. (Pubitemid 36337925)
9. Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science 1990; 247: 470-3.
10. Cronin M, Anderson PN, Cook JE, Green CR, Becker DL. Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury. Mol Cell Neurosci 2008; 39: 152-60.
11. Danesh-Meyer HV, Huang R, Nicholson LFB, Green CR. Connexin43 antisense oligodeoxynucleotide treatment down-regulates the inflammatory response in an in vitro interphase organotypic culture model of optic nerve ischaemia. J Clin Neurosci 2008; 15: 1253-63.
12. Das S, Lin D, Jena S, Shi A, Battina S, Hua DH, et al. Protection of retinal cells from ischemia by a novel gap junction inhibitor. Biochem Biophys Res Commun 2008; 373: 504-8.
13. De Bock M, Culot M, Wang N, Bol M, Decrock E, De Vuyst E, et al. Connexin channels provide a target to manipulate brain endothelial calcium dynamics and blood-brain barrier permeability. J Cereb Blood Flow Metab 2011; 31: 1942-57.
14. DePaola N, Davies PF, Pritchard WF Jr, Florez L, Harbeck N, Polacek DC. Spatial and temporal regulation of gap junction connexin43 in vascular endothelial cells exposed to controlled disturbed flows in vitro. Proc Natl Acad Sci USA 1999; 96: 3154-9. (Pubitemid 29148860)
15. Farahani R, Pina-Benabou MH, Kyrozis A, Siddiq A, Barradas PC, Chiu F-C, et al. Alterations in metabolism and gap junction expression may determine the role of astrocytes as "good samaritans" or executioners. Glia 2005; 50: 351-61. (Pubitemid 40789963)
16. Fletcher EL, Hack I, Brandstatter JH, Wassle H. Synaptic localization of NMDA receptor subunits in the rat retina. J Comp Neurol 2000; 420: 98-112. (Pubitemid 30207236)
17. Frantseva MV, Kokarovtseva L, Perez Velazquez JL. Ischemia-induced brain damage depends on specific gap-junctional coupling. J Cereb Blood Flow Metab 2002a; 22: 453-62. (Pubitemid 34273601)
18. Frantseva MV, Kokarovtseva L, Naus CG, Carlen PL, MacFabe D, Perez Velazquez JL. Specific gap junctions enhance the neuronal vulnerability to brain traumatic injury. J Neurosci 2002b; 22: 644-53. (Pubitemid 34141745)
19. Garcia-Dorado D, Inserte J, Ruiz-Meana M, Gonzalez MA, Solares J, Julia M, et al. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion. Circulation 1997; 96: 3579-86. (Pubitemid 27513436)
20. Geyer O, Almog J, Lupu-Meiri M, Lazar M, Oron Y. Nitric oxide synthase inhibitors protect rat retina against ischemic injury. FEBS Lett 1995; 374: 399-402.
21. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 2003; 4: 285-94. (Pubitemid 36383955)
22. Gwon JS, Ju WK, Park SJ, Kim IB, Lee MY, Oh SJ, et al. The regulatory expression of neuronal nitric oxide synthase in the ischemic rat retina. Neuroreport 2001; 12: 3385-9.
23. Hangai M, Yoshimura N, Hiroi K, Mandai M, Honda Y. Inducible nitric oxide synthase in retinal ischemia-reperfusion injury. Exp Eye Res 1996; 63: 501-9. (Pubitemid 26420791)
24. Haupt C, Witte OW, Frahm C. Temporal profile of connexin 43 expression after photothrombotic lesion in rat brain. Neuroscience 2007; 144: 562-70. (Pubitemid 44855313)
25. Hawat G, Benderdour M, Rousseau G, Baroudi G. Connexin 43 mimetic peptide Gap26 confers protection to intact heart against myocardial ischemia injury. Pflugers Arch 2010; 460: 583-92.
26. Hossain MZ, Peeling J, Sutherland GR, Hertzberg EL, Nagy JI. Ischemia-induced cellular redistribution of the astrocytic gap junctional protein connexin43 in rat brain. Brain Res 1994; 652: 311-22. (Pubitemid 24227287)
27. Ju WK, Gwon JS, Kim KY, Oh SJ, Kim SY, Chun MH. Up-regulated eNOS protects blood-retinal barrier in the L-arginine treated ischemic rat retina. Neuroreport 2001; 12: 2405-9.
28. Ju WK, Kim KY, Park SJ, Park DK, Park CB, Oh SJ, et al. Nitric oxide is involved in sustained and delayed cell death of rat retina following transient ischemia. Brain Res 2000; 881: 231-6.
29. Kaur C, Ling EA. Blood brain barrier in hypoxic-ischemic conditions. Curr Neurovasc Res 2008; 5: 71-81. (Pubitemid 351302657)
30. Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: Basic concepts, clinical features and management. Prog Retinal Eye Res 2008; 27: 622-47.
31. Kaur C, Sivakumar V, Yong Z, Lu J, Foulds WS, Ling EA. Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration. J Pathol 2007; 212: 429-39. (Pubitemid 47099020)
32. Kerr NM, Johnson CS, de Souza CF, Chee K-S, Good WR, Green CR, et al. Immunolocalization of gap junction protein connexin43 in the human retina and optic nerve. Invest Ophthalmol Vis Sci 2010; 51: 4028-34.
33. Kim JH, Kim JH, Park JA, Lee S-W, Kim WJ, Yu YS, et al. Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol 2006; 39: 339-45. (Pubitemid 44371860)
34. Kimelberg HK, Nedergaard M. Functions of astrocytes and their potential as therapeutic targets. Neurotherapeutics 2010; 7: 338-53.
35. Lam TT, Tso MO. Nitric oxide synthase (NOS) inhibitors ameliorate retinal damage induced by ischemia in rats. Res Commun Mol Pathol Pharmacol 1996; 92: 329-40. (Pubitemid 26243052)
36. Lee IH, Eva L, Ole K, Johan W, Lars O. Glial and neuronal connexin expression patterns in the rat spinal cord during development and following injury. J Comp Neurol 2005; 489: 1-10.
37. Lin B, Martin PR, Grunert U. Expression and distribution of ionotropic glutamate receptor subunits on parasol ganglion cells in the primate retina. Vis Neurosci 2002; 19: 453-65. (Pubitemid 36019867)
38. Lin JH, Weigel H, Cotrina ML, Liu S, Bueno E, Hansen AJ, et al. Gap-junction-mediated propagation and amplification of cell injury. Nat Neurosci 1998; 1: 494-500.
39. Nagy JI, Rash JE. Connexins and gap junctions of astrocytes and oligodendrocytes in the CNS. Brain Res Rev 2000; 32: 29-44. (Pubitemid 30177308)
40. Nakase T, Yoshida Y, Nagata K. Enhanced Connexin 43 immunoreactivity in penumbral areas in the human brain following ischemia. Glia 2006; 54: 369-75. (Pubitemid 44422939)
41. Nakase T, Sohl G, Theis M, Willecke K, Naus CCG. Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes. Am J Pathol 2004; 164: 2067-75. (Pubitemid 38669354)
42. Naus CC, Bechberger JF, Caveney S, Wilson JX. Expression of gap junction genes in astrocytes and C6 glioma cells. Neurosci Lett 1991; 126: 33-6.
43. Naus CC, Ozog MA, Bechberger JF, Nakase T. A neuroprotective role for gap junctions. Cell Commun Adhes 2001; 8: 325-8. (Pubitemid 34982310)
44. Neufeld AH, Kawai Si, Das S, Vora S, Gachie E, Connor JR, et al. Loss of retinal ganglion cells following retinal ischemia: the role of inducible nitric oxide synthase. Exp Eye Res 2002; 75: 521-8. (Pubitemid 35435607)
45. O'Carroll SJ, Alkadhi M, Nicholson LF, Green CR. Connexin 43 mimetic peptides reduce swelling, astrogliosis, and neuronal cell death after spinal cord injury. Cell Commun Adhes 2008; 15: 27-42.
46. Ohsumi A, Nawashiro H, Otani N, Ooigawa H, Toyooka T, Yano A, et al. Alteration of gap junction proteins (connexins) following lateral fluid percussion injury in rats. Acta Neurochir Suppl 2006; 96: 148-50.
47. Orellana JA, Saez PJ, Shoji KF, Schalper KA, Palacios-Prado N, Velarde V, et al. Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration. Antioxid Redox Signal 2009; 11: 369-99.
48. Osborne NN, Casson RJ, Wood JP, Chidlow G, Graham M, Melena J. Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog Retin Eye Res 2004; 23: 91-147. (Pubitemid 38180539)
49. Pachter JS, de Vries HE, Fabry Z. The blood-brain barrier and its role in immune privilege in the central nervous system. J Neuropathol Exp Neurol 2003; 62: 593-604. (Pubitemid 36682632)
50. Petito CK. Early and late mechanisms of increased vascular permeability following experimental cerebral infarction. J Neuropathol Exp Neurol 1979; 38: 222-34. (Pubitemid 9179809)
51. Rami A, Volkmann T, Winckler J. Effective reduction of neuronal death by inhibiting gap junctional intercellular communication in a rodent model of global transient cerebral ischemia. Exp Neurol 2001; 170: 297-304. (Pubitemid 32758683)
52. Rawanduzy A, Hansen A, Hansen TW, Nedergaard M. Effective reduction of infarct volume by gap junction blockade in a rodent model of stroke. J Neurosurg 2009; 87: 916-20.
53. Rodriguez-Sinovas A, Cabestrero A, Lopez D, Torre I, Morente M, Abellan A, et al. The modulatory effects of connexin 43 on cell death/survival beyond cell coupling. Prog Biophys Mol Biol 2007; 94: 219-32. (Pubitemid 46782978)
54. Rouach N, Avignone E, Meme W, Koulakoff A, Venance L, Blomstrand F, et al. Gap junctions and connexin expression in the normal and pathological central nervous system. Biol Cell 2002; 94: 457-75. (Pubitemid 36113697)
55. Shen W, Li S, Chung SH, Gillies MC. Retinal vascular changes after glial disruption in rats. J Neurosci Res 2010; 88: 1485-99.
56. Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M. Signaling at the gliovascular interface. J Neurosci 2003; 23: 9254-62. (Pubitemid 37243827)
57. Sun D, Vingrys AJ, Kalloniatis M. Metabolic and functional profiling of the ischemic/reperfused rat retina. The J Comp Neurol 2007; 505: 114-30. (Pubitemid 350068233)
58. Wilson CA, Berkowitz BA, Funatsu H, Metrikin DC, Harrison DW, Lam MK, et al. Blood-retinal barrier breakdown following experimental retinal ischemia and reperfusion. Exp Eye Res 1995; 61: 547-57.
59. Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 2011; 42: 3323-8.
60. Yeh H-I, Lai Y-J, Chang H-M, Ko Y-S, Severs NJ, Tsai C-H. Multiple Connexin Expression in Regenerating Arterial Endothelial Gap Junctions. Arterioscler Thromb Vasc Biol 2000; 20: 1753-62. (Pubitemid 30470590)
61. Yoon JJ, Green CR, O'Carroll SJ, Nicholson LF. Dose-dependent protective effect of connexin43 mimetic peptide against neurodegeneration in an ex vivo model of epileptiform lesion. Epilepsy Res 2010; 92: 153-62.
62. Zahs KR, Kofuji P, Meier C, Dermietzel R. Connexin immunoreactivity in glial cells of the rat retina. The J Comp Neurol 2003; 455: 531-46. (Pubitemid 36043654)
63. Zhang J, O'Carroll SJ, Wu A, Nicholson LF, Green CR. A model for ex vivo spinal cord segment culture-a tool for analysis of injury repair strategies. J Neurosci Methods 2010; 192: 49-57.
64. Zheng L, Gong B, Hatala DA, Kern TS. Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes. Invest Ophthalmol Vis Sci 2007; 48: 361-7. (Pubitemid 47251425)
65. Zhou Y, Shi G, Zheng J, Huang Z, Gao F, Zhang Y, et al. The protective effects of Egr-1 antisense oligodeoxyribonucleotide on cardiac microvascular endothelial injury induced by hypoxia-reoxygenation. Biochem Cell Biol 2010; 88: 687-95.